help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Daud, A. I.
Right arrow Articles by Husain, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Daud, A. I.
Right arrow Articles by Husain, A.

Endocrinology, Vol 126, 2927-2935, Copyright © 1990 by Endocrine Society


ARTICLES

Characterization of angiotensin I-converting enzyme (ACE)-containing follicles in the rat ovary during the estrous cycle and effects of ACE inhibitor on ovulation

AI Daud, FM Bumpus and A Husain
Department of Heart and Hypertension Research, Research Institute of the Cleveland Clinic Foundation, Ohio 44195-5071.

Ovarian angiotensin I (Ang I)-converting enzyme (ACE), estimated by the specific binding of the ACE inhibitor [125I]iodo-MK-351A, is localized on multiple ovarian structures, including follicular granulosa cells, corpora lutea, terminal epithelium, and ovarian blood vessels, but total ovarian ACE does not display a cyclic pattern of variation during the rat estrous cycle. We have previously shown that ACE is localized on the granulosa cell layer of a subpopulation of rat ovarian follicles. Our present study shows that ovarian granulosa cells contain high affinity [binding site affinity (Kd), approximately 90 pM] and low capacity [binding site density (Bmax), approximately 12 fmol/2.5 X 10(5) cells] [125I]iodo-MK-351A-binding sites and convert [125I]iodo- Ang I to [125I]iodo-Ang II (greater than 85% of this conversion was inhibited by the ACE inhibitor captopril). Throughout the rat estrous cycle, 94-100% of developing follicles and 89-96% of atretic follicles contained high levels of ACE; however, ACE was either not observed or its levels were very low in preovulatory follicles. These findings indicate the presence of high levels of biologically active ACE on the surface of granulosa cells and suggest a potential role for follicular ACE in early stages of follicular maturation and atresia. Although ACE is known to process a variety of peptides found within the ovary, and these peptides may have opposing effects on follicular maturation, we attempted to define the cumulative effect of ACE inhibition on follicular maturation. Short and long term (6- and 14-day) infusions of captopril (6-day, 30.5 +/- 3.5 ova; 14-day, 28.5 +/- 7.5 ova) in immature rats, in which ovulation was induced by sequential treatments with PMSG and hCG, did not significantly affect ovulation compared with that in vehicle-infused control rats (6-day, 22.4 +/- 2.4 ova; 14-day, 20.8 +/- 3.1 ova), suggesting that ACE inhibition does not modify the follicular selection process in a way that affects ovulation. This may explain the lack of any reports of adverse effects of clinically used ACE inhibitors on ovulation.


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. R. Pepperell, G. Nemeth, Y. Yamada, F. Naftolin, and M. Merino
Localized accumulation of angiotensin II and production of angiotensin-(1-7) in rat luteal cells and effects on steroidogenesis
Am J Physiol Endocrinol Metab, August 1, 2006; 291(2): E221 - E233.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E. V. Bokal, H. M. Vrtovec, I. V. Klun, and I. Verdenik
Prolonged HCG action affects angiogenic substances and improves follicular maturation, oocyte quality and fertilization competence in patients with polycystic ovarian syndrome
Hum. Reprod., June 1, 2005; 20(6): 1562 - 1568.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. P. R. Costa, C. R. Fagundes-Moura, V. M. Pereira, L. F. Silva, M. A. R. Vieira, R. A. S. Santos, and A. M. Dos Reis
Angiotensin-(1-7): A Novel Peptide in the Ovary
Endocrinology, May 1, 2003; 144(5): 1942 - 1948.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K.H. Schauser, A.H. Nielsen, H. Winther, V. Dantzer, and K. Poulsen
Localization of the Renin-Angiotensin System in the Bovine Ovary: Cyclic Variation of the Angiotensin II Receptor Expression
Biol Reprod, December 1, 2001; 65(6): 1672 - 1680.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. Antczak and J. Van Blerkom
The vascular character of ovarian follicular granulosa cells: phenotypic and functional evidence for an endothelial-like cell population
Hum. Reprod., November 1, 2000; 15(11): 2306 - 2318.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J. Gutkowska, M. Jankowski, M. Ram Sairam, N. Fujio, A. M. Reis, S. Mukaddam-Daher, and J. Tremblay
Hormonal Regulation of Natriuretic Peptide System during Induced Ovarian Follicular Development in the Rat
Biol Reprod, July 1, 1999; 61(1): 162 - 170.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Bramucci, A. Miano, A. Gobbetti, M. Zerani, L. Quassinti, E. Maccari, O. Murri, and D. Amici
Different modulation of steroidogenesis and prostaglandin production in frog ovary in vitro by ACE and ANG II
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 1997; 273(6): R2089 - R2096.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society